Sugars could be biology's next sweet spot.
It takes years and millions to get a new drug to market. New techniques might burrow through the mountain of genome data and break the bottleneck.
From the editor in chief
Individual sequencing could be around the corner.
Now that the human genome project is done, proteins are set to displace genes as the new darlings of drug discovery. But are biologists up to the task?
The CEO of Human Genome Sciences, Bill Haseltine, has created a powerful new tool that he just knows will revolutionize the discovery of new medicines.
Will Web-wide "translation memory" finally make machine translation pay off?